[1]
“MONOCLONAL ANTIBODIES TARGETING CGRP IN MIGRAINE: CURRENT PERSPECTIVES AND CLINICAL GUIDELINES”, IJITSS, vol. 3, no. 3(47), Sep. 2025, doi: 10.31435/ijitss.3(47).2025.3641.